01/28/2025
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
01/28/2025
3:16 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/23/2025
2:45 PM | Orca Capital AG (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/21/2025
3:39 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
3:44 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/17/2025
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/15/2025
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/14/2025
4:18 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
12:34 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/13/2025
9:55 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:06 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Get the Latest News and Ratings for PHIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/27/2024
4:05 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/26/2024
1:19 PM | CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/23/2024
3:05 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
12/19/2024
7:38 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
10:20 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
9:21 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
1:59 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
1:59 PM | Freeman Jonathan E (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
2:00 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:10 PM | BRADFORD PATRICIA A (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | Lockshin Curtis (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:14 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:45 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
8:05 AM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
08/01/2024
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
08/01/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/24/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
7:01 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
06/21/2024
3:45 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:04 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
05/17/2024
8:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:20 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:23 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
4:05 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form PRE 14A | |
Elon Social Security shock? (Ad) “A Maniacal Sense of Urgency”
We could be just days away from Elon Musk launching his next big venture. One Boston based think tank believes it could have drastic impacts on your money and life in America. Get the details here. |
04/02/2024
6:30 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:31 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
3:42 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
6:00 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:03 PM | Kontulis Caitlin (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
9:30 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
